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Evidence from many experiments and observations sug-
gests that the likelihood of ventricular fibrillation is in-
creased in some proportion to the magnitude of local
differences in the electrophysiologic state of the ventric-
ular myocardium. Many local anesthetic antiarrhythmic
drugs have differing affinities for resting, open and in-
activated fast channels. In ischemic or otherwise dam-
aged hearts, local differences in resting potential, action
Fibrillation occurs when the wave front of the impulse prop-
agating in the ventricles fractionates to form a sufficient
number of reentrant circuits (l,2). For the fibrillation to
persist, the mass of the ventricles must be great enough to
sustain multiple reentrant circuits (3), depending on the
imbalance between the duration of refractoriness and the
speed of conduction. In ventricles of sufficient size, no other
special conditions are necessary for initiation of fibrillation
because the arrhythmia can be started by single, properly
timed premature impulses or by a progressively accelerating
tachycardia (4,5). In human subjects, evidence for the vul-
nerability of normal ventricles is provided by hearts in which
there is an accessory atrioventricular pathway with a short
anterograde effective refractory period. Among the most
important conditions that increase the likelihood of ventric-
ular arrhythmias and probably predispose to fibrillation are:
1) localized differences in the duration of refractoriness or
the period of reduced responsiveness (6), 2) localized dif-
ferences in the effectiveness of impulse propagation, and
3) localized abnormalities of structure and interfiber com-
munications (7). In the presence of localized differences in
the rate of recovery of full responsiveness, a premature
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potential upstroke and action potential duration wUl re-
sult in differing degrees of block of fast channels by local
anesthetic antiarrhythmic drugs. Such drugs can beex-
pected to add to the preexisting local inhomogeneities of
electrophysiologic state and thereby increase the likeli-
hood of fibrillation.
(J Am Coll CardioI1985;5:28B-30B)
impulse is more likely to block in some areas while still
propagating in others and in this way establish multiple
reentrant circuits.
Effect of Antiarrhythmic Drugs
To reduce the likelihood of fibrillation it thus would seem
reasonable to attempt both to prevent premature or other
inciting impulses and to decrease the magnitude and extent
of local differences in electrophysiologic properties such as
refractoriness and safety factor for impulse propagation. It
is important to realize that many of the antiarrhythmic drugs
administered to prevent or partially suppress ectopic im-
pulses and repetitive ventricular responses can, under ap-
propriate conditions, significantly increase both local dif-
ferences in the duration of the period of refractoriness or
reduced responsiveness and local differences in the speed
and certainty of impulse propagation. The antiarrhythmic
drugs most likely to do this can be classified as local an-
esthetics since they block fast inward channels in a dose-
dependent manner. The basis for the undesirable effects
results directly from their mechanism of action. All of these
drugs show a property described as "use-dependence" (8,9).
This means that the intensity of effect at a constant con-
centration is a function of the repetition rate of the action
potentials. Thus at a low heart rate and a given drug plasma
level, there might be little block of fast inward channels
and little drug effect on impulse conduction or refractori-
ness. At a more rapid heart rate, however, block of fast
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channels would increase and effects of the drug on both
conduction and recovery of responsiveness would be
intensified.
The dependence of the intensity of effect on the interval
between action potentials is generally assumed to result from
a change in affinity of the drug receptor in the fast channel
when the channel passes from the resting, to the open and
to the inactivated states (8,10). The affinity of a drug for
the channels in the inactivated state typically is much higher
than for the resting channel (11). Thus with each action
potential, as the channels enter the inactivated state they
bind drug. Moreover, the drug-complexed inactivated chan-
nel requires a transmembrane potential more negative than
the normal resting potential for all of the inactivated chan-
nels to return to the rest state .
Tocainide. An example of the development of use-de-
pendent block of fast channels in canine Purkinje fibers by
tocainide is shown in Figure I. At a low rate of stimulation,
vmax, the maximal slope of phase 0, is reduced only slightly
from control, but with the onset of more rapid stimulation
\!max decreases exponentially to a much lower value. For
this example, changes in \!max are assumed to occur in
parallel with changes in blockade of fast sodium channels.
If the rate of stimulation is then reduced, the increment in
block disappears with a time constant typical of the drug
employed. The rate of development of block during rapid
stimulation is a function of the drug and drug concentration;
the rate at which the drug dissociates from blocked channels
is a property of the drug. If the rates of association and
dissociation are quite fast, as for lidocaine, use-dependent
block will be prominent only at short cycle lengths. Con-
versely, if association is rapid and dissociation relatively
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Figure 1. The effect of tocainide concentration on the rate of
development and recovery from use-dependent block. A, After
maximal rest recovery with either 4 x 10-5 M (A) or I x 10- 4
M (e) of tocainide, the decline in the maximal slope of phase 0(Vmax) during stimulation has been plotted on a logarithmic scale
as the difference between Vmax obtained at the beginning of the
stimulus train and the final reduced value of Vmax' T(tau) the time
constant for association of drug with channel decreased from 6.1
to 3.4 beats after the increase in drug concentration. Basic cycle
length = 400 ms. Inset, Representative action potential config-
uration changes caused by tocainide. Upper trace = control,
lower trace = I x 10- 4 M of tocainide. Calibrations show 50
ms and 20 mV for voltage traces and 0.5 ms and 200 Vis for dV/dt
(rate on change or voltage with time). B, The time course of Vmax
recovery plotted as the percent of maximal rest recovery. Increas-
ing the drug concentration did not influence the rate of recovery
of Vmax (same fiber as in A). [K"], = 5 mM. Inset, Chart re-
cording from a similar experiment illustrating protocol. Upper
trace represents Vmax signal from peak hold circuit; lower trace
displays transmembrane potential. Calibrations: 100 Vis and 50
mV vertical, 5 seconds horizontal. (Reproduced from Gintant GA,
et al. [14] by permission of the American Heart Association, Inc.)
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Figure 2. The local anesthetic effects of benzocaine. A, Control
was first determined by varying [K ']0 in steps from 2.7 to 12 mM,
noting the maximal slope of phase 0 (Vmax) and corresponding
membrane activation voltage (MAV) values (e). This sequence
was then repeated after equilibration with benzocaine. Shortening
the basic cycle length (BCL) from greater than I second (e, 0) to
250 ms (A, 6) resulted in slight reductions of Vmax of similar
magnitude during superfusion with either benzocaine (open sym-
bols) or drug-free Tyrode's solution (closed symbols). (Repro-
duced from Gintant GA, et al. [14] by permission of the American
Heart Association, Inc.)
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slow, as is the case for many antiarrhythmic drugs (11),
only a few action potentials in rapid succession will be
enough to cause a marked increase in the degree of block.
Benzocaine. Figure 2 shows the effect of this local an-
esthetic antiarrhythmic drug on the relation between mem-
brane potential and Vmax' The control curve shows the usual
relation, with the maximal value of Vmax obtained at mem-
brane potentials equal to or slightly negative to the normal
resting potential, and a reduction in Vmax to 50% at a mem-
brane potential around - 70 mV. In the presence of the
drug, the curve is shifted to the right, that is, to more
negative potentials. Under this condition, Vmax is not re-
stored to its maximal value at the normal resting potential,
and the 50% reduction occurs at a potential more negative
than - 70 mV. The effect of this apparent shift of the curve
on refractoriness and conduction can be significant.
Localized inhomogeneities of conduction and refrac-
toriness. The ability of this type of drug action to cause
localized inhomogeneities of conduction and refractoriness
in the ventricles is clear. At a normal heart rate, if resting
potential in some area has been reduced by ischemia, drug
effect in this area will be more intense than elsewhere be-
cause a greater than usual fraction of fast channels will
persist in the inactivated state. As a result, the safety factor
for impulse propagation will be reduced, even above the
reduction resulting directly from the reduced resting poten-
tial. Since current in fast channels contributes to action
potential duration (12,13), the augmented block offast chan-
nels may cause a local reduction in action potential duration.
More important, however, will be a local increase in the
period of refractoriness and reduced responsiveness. This
happens because at a less negative resting potential, the
dissociationof drug from inactivated channels will be slowed.
If, under the same conditions, there was an increase in heart
rate, the changes just described would be intensified to a
degree that caused marked slowing of impulse propagation
in the ischemic area with the development of local areas of
block. A similar increase in inhomogeneity of refractoriness
might occur as a consequence of a significant decrease in
heart rate. In this case, one can assume that before the period
of cardiac slowing, block of sodium channels by local an-
esthetic had decreased action potential duration throughout
the ventricles. With the onset of the long cardiac cycles,
action potential duration in normally polarized areas will
increase significantly as use-dependent block of fast chan-
nels diminishes. In partially depolarized areas, dissociation
of drug from fast channels will be less complete and the
action potential and refractory period will remain short.
Matrix for repetitive ventricular responses and fi-
brillation. Local differences in the functional properties of
the ventricles seem to increase the likelihood of repetitive
responses and fibrillation or rapid stimulation. The mode
of action of many local anesthetic antiarrhythmic drugs sug-
gests that they have the potential to greatly increase the
degree of functional inhomogeneity and thus create a matrix
suitable for sudden death.
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